申请人:Sharpe Arlene H.
公开号:US20130022629A1
公开(公告)日:2013-01-24
Disclosed are an assay to identify modulators of the PD-1:PD-L pathway and PD-1:PD-L pathway modulators, e.g., compounds and pharmaceutical compositions thereof. Methods for treating diseases influenced by modulation of the PD-1:PD-L pathway such as, for example, autoimmune diseases, inflammatory disorders, allergies, transplant rejection, cancer, immune deficiency, and other immune system-related disorders, are also disclosed.
本发明揭示了一种鉴定PD-1:PD-L途径调节剂的测定方法和PD-1:PD-L途径调节剂,例如,化合物和制药组合物。本发明还揭示了通过调节PD-1:PD-L途径治疗受PD-1:PD-L途径调节影响的疾病的方法,例如自身免疫疾病、炎症性疾病、过敏、移植排斥、癌症、免疫缺陷和其他与免疫系统相关的疾病。